Anti-inflammatory, antioxidant and immunomodulatory effects of curcumin in sensitized rat Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017
LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015
A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: Lung Science Conference 2015 Year: 2015
In vitro and in vivo pharmacological profile of RP6503, a novel dual PI3K Δ/gamma inhibitor, in pulmonary disease systemsSource: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013
In vitro anti-inflammatory activity of the new glucocorticoid ciclesonide in human cellsSource: Eur Respir J 2001; 18: Suppl. 33, 95s Year: 2001
Sirtuins, the anti-ageing molecules, regulate anti-oxidant capacity via FoxO3 activity in monocytic cell line Source: Annual Congress 2011 - Phagocytes and dendritic cells Year: 2011
Anti-oxidative and anti-inflammatory effects of Xanthorrhizol on aeroallergens-induced biological responses in vitro and ex vivo Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019
In vitro pharmacological profile of SMP-028, a novel potent anti-inflammatory agentSource: Annual Congress 2010 - Models of airways disease Year: 2010
In vitro and in vivo anti-inflammatory activity of the novel PDE4 inhibitor roflumilastSource: Eur Respir J 2001; 18: Suppl. 33, 35s Year: 2001
Effect of non-steroidal anti-inflammatory drugs on neutrophil recruitment, p38 map kinase phosphorylation and NF-κB activation in lung from mice exposed to cigarette smoke Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma Year: 2007
Novel anti-inflammatory agents Source: Annual Congress 2009 - Emerging trends in the therapy of COPD Year: 2009
A combination of thyme and ivy exerts potent anti-inflammatory and mucus-normalizing activity in vivo and inhibits 5-LO and PDE4 Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014
Production of alpha-1 antitrypsin by pro- and anti-inflammatory macrophages Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010
Human Airway Trypsin-like protease exerts potent anti-fibrotic role in vivo. Source: International Congress 2017 – Rare diseases Year: 2017
Inhibitory effect of statins on fibrogenic mediator production from lung cells Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012
A decoy CXCL8 with increased glycosaminoglycan binding has potent anti-inflammatory activity in lung inflammation models Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010
Demonstration of anti-inflammatory properties of an inhaled p38 inhibitor AZD7624 Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015
Proapoptotic and anti-proliferative effect of the stable plasminogen activator inhibitor type 1 (PAI-1) mutant on the lung cancer and endothelial cells Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009
Influence of antibiotics on neutrophil functional activity Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007
Defect of sirtuin, an anti-aging molecule, reduces anti-oxidative stress capacity in THP-1 cell line Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010